Cargando…
Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer
BACKGROUND AND OBJECTIVE: Differentiated thyroid carcinoma (DTC) is a slow-growing tumour with 20% of the cases having distant metastasis. Its prognosis can vary by its histological characteristics, extension and spread. The data on metastatic DTC patients in Pakistan is scarce; therefore, the purpo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302427/ https://www.ncbi.nlm.nih.gov/pubmed/35873927 http://dx.doi.org/10.4103/ijem.ijem_455_21 |
_version_ | 1784751633536647168 |
---|---|
author | Aziz, Abdul Khan, Sajjad Ali Suchal, Zafar A. Islam, Najmul |
author_facet | Aziz, Abdul Khan, Sajjad Ali Suchal, Zafar A. Islam, Najmul |
author_sort | Aziz, Abdul |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Differentiated thyroid carcinoma (DTC) is a slow-growing tumour with 20% of the cases having distant metastasis. Its prognosis can vary by its histological characteristics, extension and spread. The data on metastatic DTC patients in Pakistan is scarce; therefore, the purpose of our study was to assess the clinicopathological characteristics and treatment outcomes of metastatic DTC in our population. METHODS: This retrospective, single-centre study was carried out on 117 patients with metastatic DTC with their age at diagnosis, gender, tumour size and extent and spread of the tumour, and its histologic characteristic recorded. The treatment they received and the outcome in terms of status, at last, follow-up were also recorded. RESULTS: The mean age of diagnosis was found to be 46.6 ± 17.2 years with an almost equal male to female ratio. The most common site of metastasis was the lung followed by bone. Papillary carcinoma was the most common subtype with 89.7% of the cases followed by follicular carcinoma occurring in 7.7%. The overall survival in years was found to be 5.6 ± 2.6 years. Ninety-six per cent had complete surgical resection followed by radioactive iodine (RAI) in 91.5%. CONCLUSION: Our study shows that the most significant factors in predicting the outcome in metastatic DTC are age, an extrathyroidal extension of the primary tumour and distant metastasis. However, further multicentric studies done on a much larger population will be needed to further support and strengthen our results. |
format | Online Article Text |
id | pubmed-9302427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-93024272022-07-22 Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer Aziz, Abdul Khan, Sajjad Ali Suchal, Zafar A. Islam, Najmul Indian J Endocrinol Metab Original Article BACKGROUND AND OBJECTIVE: Differentiated thyroid carcinoma (DTC) is a slow-growing tumour with 20% of the cases having distant metastasis. Its prognosis can vary by its histological characteristics, extension and spread. The data on metastatic DTC patients in Pakistan is scarce; therefore, the purpose of our study was to assess the clinicopathological characteristics and treatment outcomes of metastatic DTC in our population. METHODS: This retrospective, single-centre study was carried out on 117 patients with metastatic DTC with their age at diagnosis, gender, tumour size and extent and spread of the tumour, and its histologic characteristic recorded. The treatment they received and the outcome in terms of status, at last, follow-up were also recorded. RESULTS: The mean age of diagnosis was found to be 46.6 ± 17.2 years with an almost equal male to female ratio. The most common site of metastasis was the lung followed by bone. Papillary carcinoma was the most common subtype with 89.7% of the cases followed by follicular carcinoma occurring in 7.7%. The overall survival in years was found to be 5.6 ± 2.6 years. Ninety-six per cent had complete surgical resection followed by radioactive iodine (RAI) in 91.5%. CONCLUSION: Our study shows that the most significant factors in predicting the outcome in metastatic DTC are age, an extrathyroidal extension of the primary tumour and distant metastasis. However, further multicentric studies done on a much larger population will be needed to further support and strengthen our results. Wolters Kluwer - Medknow 2022 2022-06-06 /pmc/articles/PMC9302427/ /pubmed/35873927 http://dx.doi.org/10.4103/ijem.ijem_455_21 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Aziz, Abdul Khan, Sajjad Ali Suchal, Zafar A. Islam, Najmul Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer |
title | Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer |
title_full | Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer |
title_fullStr | Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer |
title_full_unstemmed | Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer |
title_short | Clinicopathological Characteristics and Treatment Outcome of Patients with Metastatic Differentiated Thyroid Cancer |
title_sort | clinicopathological characteristics and treatment outcome of patients with metastatic differentiated thyroid cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302427/ https://www.ncbi.nlm.nih.gov/pubmed/35873927 http://dx.doi.org/10.4103/ijem.ijem_455_21 |
work_keys_str_mv | AT azizabdul clinicopathologicalcharacteristicsandtreatmentoutcomeofpatientswithmetastaticdifferentiatedthyroidcancer AT khansajjadali clinicopathologicalcharacteristicsandtreatmentoutcomeofpatientswithmetastaticdifferentiatedthyroidcancer AT suchalzafara clinicopathologicalcharacteristicsandtreatmentoutcomeofpatientswithmetastaticdifferentiatedthyroidcancer AT islamnajmul clinicopathologicalcharacteristicsandtreatmentoutcomeofpatientswithmetastaticdifferentiatedthyroidcancer |